Perspectives on microbes as oncogenic infectious agents and implications for breast cancer

Medical Hypotheses

Volumn 71, Issue 2, 2008, Pages 302-306

  Nackerdien, Zeena E ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; PROBIOTIC AGENT;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CHRONIC DISEASE; DIGESTIVE SYSTEM CANCER; EPIGENETICS; GENETIC DAMAGE; HOST PARASITE INTERACTION; IMMUNE SYSTEM; IMMUNOTHERAPY; INFECTION; LIVER CANCER; LUNG CANCER; MICROORGANISM; PRIORITY JOURNAL; SIDE EFFECT; STRAIN DIFFERENCE; TUMOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMMUNICABLE DISEASES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTESTINES; MICE; MODELS, BIOLOGICAL; MODELS, GENETIC; MODELS, THEORETICAL; PROBIOTICS;

EID: 45649084475     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.02.016     Document Type: Article

References (50)

1. Cairns J. Matters of life and death: perspectives on public health, molecular biology, cancer and the prospects for the human race. Princeton (1997), Princeton Academic Press, New Jersey 257p
2. Madigan M.P., Ziegler R.G., Benichou J., Byrne C., and Hoover R.N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Nat Cancer Instit 87 (2005) 1681-1685
3. Satia J.A., and Galanko J.A. Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans. J Health Care Poor Under 18 Suppl. 4 (2007) 146-164
4. Ghafoor A., Jemal A., Ward E., Cokkinides V., Smith R., and Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53 6 (2003) 342-355
5. Chlebowski R.T., and Blackburn G.L. Diet and breast cancer recurrence. JAMA 298 18 (2007) 2135 [author reply 2135-6]
6. De Assis S., and Hilakivi-Clarke L. Timing of dietary estrogenic exposures and breast cancer risk. Ann NY Acad Sci 1089 (2006) 14-35
7. Thomas W., Caiazza F., and Harvey B.J. Estrogen, phospholipase A and breast cancer. Front Biosci 13 (2008) 2604-2613
8. DeNardo D.G., and Coussens L.M. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9 4 (2007) 212
9. David H. Rudolf Virchow and modern aspects of tumor pathology. Pathol Res Pract 183 3 (1988) 356-364
10. Melana S.M., Nepomnaschy I., Sakalian M., Abbott A., Hasa J., Holland J.F., et al. Characterization of viral particles isolated from primary cultures of human breast cancer cells. Cancer Res 67 18 (2007) 8960-8965
11. Wang Y., Pelisson I., Melana S.M., Go V., Holland J.F., and Pogo B.G. MMTV-like env gene sequences in human breast cancer. Arch Virol 146 1 (2001) 171-180
12. Pogo B.G., and Holland J.F. Possibilities of a viral etiology for human breast cancer. A review. Biol Trace Elem Res 56 1 (1997) 131-142
13. Cantwell Jr. AR. The cancer microbe (1990), Aries Rising Press, Los Angeles
14. Tamaki K., Kogata Y., Sugiyama D., Nakazawa T., Hatachi S., Kageyama G., et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol 35 1 (2008) 114-119
15. Astrauskiene D., and Bernotiene E. New insights into bacterial persistence in reactive arthritis. Clin Exp Rheumatol 25 3 (2007) 470-479
16. Marx J. Inflammation and cancer: the link grows stronger. Science 306 (2004) 966-968
17. Fredricks D.N., and Relman D.A. Infectious agents and the etiology of chronic idiopathic diseases. Curr Clin Top Infect Dis 18 (1998) 180-200
18. O'Keefe S.J. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 24 1 (2008) 51-58
19. Franco A.T., Johnston E., Krishna U., Yamaoka Y., Israel D.A., Nagy T.A., et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 68 2 (2008) 379-387
20. Gill S.R., Pop M., DeBoy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 312 (2006) 1355-1358
21. Sfanos K.S., Sauvageot J., Fedor H.L., Dick J.D., De Marzo A.M., and Isaacs W.B. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68 3 (2008) 306-320
22. McNeill R.E., Miller N., and Kerin M.J. Evaluation and validation of candidate endogenous control genes in real-time quantitative PCR studies of breast cancer. BMC Mol Biol 8 1 (2007) 107
23. Proctor R.A., von Eiff C., Kahl B.C., Becker K., McNamara P., Herrmann M., et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4 4 (2006) 295-305
24. Cantwell Jr. A.R., and Kelso DW. Microbial findings in cancers of the breast and in their metastases to the skin. Implications for etiology. J Dermatol Surg Oncol 7 6 (1981) 483-491
25. Ewald PW. Plague time: how stealth infections cause cancers heart disease and other deadly ailments (2000), The Free Press, A Division of Simon and Schuster, New York, NY 282p
26. Casadesus J. Bacterial L-forms require peptidoglycan synthesis for cell division. Bioessays 29 12 (2007) 1189-1191
27. Morino G.F., Rizzardi G., Gobbi F., and Baldan M. Breast tuberculosis mimicking other diseases. Trop Doc 37 3 (2007) 177-178
28. Wang K.-X., and Chen L. Helicobacter pylori L-form and patients with chornic gastritis. World J Gastroenterol 10 9 (2004) 1306-1309
29. Michailova L., Kussovsky V., Radoucheva T., Jordanova M., and Markova N. Persistence of Staphylococcus aureus L-form during experimental lung infection in rats. FEMS Microbiol Lett 268 (2007) 88-97
30. Ivanova E.H., Michailova L., Stefanova Z., Neychev H., Radoevska S., and Gumpert J. Effect of Escherichia coli L-form cytoplasmic membranes on the interaction between macrophages and Lewis lung carcinoma cells: scanning electron microscopy. FEMS Immunol Med Microbiol 17 1 (1997) 27-36
31. Nuzum J. A critical study of a transplantable carcinoma of the white mouse. Surg Gynecol Obstet 33 (1921) 167-175
32. Nuzum J. The experimental production of metastasizing carcinoma in the breast of the dog in primary epithelioma in man by repeated inoculation of a micrococcus isolated from human breast cancer. Surg Gynecol Obstet 11 (1925) 343-352
33. Joseleau-Petit D., Liebart J.C., Ayala J.A., and D'Ari R. Unstable Escherichia coli L forms revisited: growth requires peptidoglycan synthesis. J Bacteriol 189 18 (2007) 6512-6520
34. Janssen P.H., Yates P.S., Grinton B.E., Taylor P.M., and Sait M. Improved culturability of soil bacteria and isolation in pure culture of novel members of the divisions Acidobacteria, Actinobacteria, Proteobacteria, and Verrucomicrobia. Appl Environ Microbiol 68 5 (2002) 2391-2396
35. Sait M., Hugenholtz P., and Janssen P.H. Cultivation of globally distributed soil bacteria from phylogenetic lineages previously only detected in cultivation-independent surveys. Environ Microbiol 4 11 (2002) 654-666
36. Lederberg J., and St Clair J. Protoplasts and L-type growth of Escherichia coli. J Bacteriol 75 2 (1958) 143-160
37. Rao V.P., Poutahidis T., Ge Z., Nambiar P.R., Boussahmain C., Wang Y.Y., et al. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 66 15 (2006) 7395-7400
38. Rao V.P., Poutahidis T., Fox J.G., and Erdman S.E. Breast cancer: should gastrointestinal bacteria be on our radar screen?. Cancer Res 67 3 (2007) 847-850
39. Rao V.P., Poutahidis T., Ge Z., Nambiar P.R., Horwitz B.H., Fox J.G., et al. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 66 1 (2006) 57-61
40. Canney P.A., Machin M.A., and Curto J. A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer. Eur J Cancer 42 16 (2006) 2751-2756
41. Mazhar D., Ang R., and Waxman J. COX inhibitors and breast cancer. Brit J Cancer 94 3 (2006) 346-350
42. Lewis C.E., and Hughes R. Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. Breast Cancer Res 9 3 (2007) 209
43. Osterlund P., Ruotsalainen T., Korpela R., Saxelin M., Ollus A., Valta P., et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Brit J Cancer 97 8 (2007) 1028-1034
44. McCarthy E.F. The toxins of William B Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 26 (2006) 154-158
45. Starnes C.O. Coley's toxins in perspective. Nature 357 6373 (2002) 11-12
46. Agrawal N., Bettegowda C., Cheong I., Geschwind J.F., Drake C.G., Hipkiss E.L., et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci USA 101 42 (2004) 15172-15177
47. Plomp M., McCaffery J.M., Cheong I., Huang X., Bettegowda C., Kinzler K.W., et al. Spore coat architecture of Clostridium novyi NT spores. J Bacteriol 189 17 (2007) 6457-6468
48. Sasaki T., Fujimori M., Hamaji Y., Hama Y., Ito K., Amano J., et al. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats. Cancer Sci 97 7 (2006) 649-657
49. Fujimori M., Amano J., and Taniguchi S. The genus Bifidobacterium for cancer gene therapy. Curr Opin Drug Discov Devel 5 2 (2002) 200-203
50. Cheong I., Huang X., Bettegowda C., Diaz LA., Kinzler KW., Zhou S., et al. A bacterial protein enhances the release and efficacy of liposomal cancer drugs. Science 314 5803 (2006) 1308-1311